P Zabel1, D T Wolter, M M Schönharting
1Forschungsinstitut Borstel, Medizinische Klinik, Federal Republic of Germany.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Oxpentifylline effectively blocks endotoxin-induced tumor necrosis factor alpha (TNF) synthesis in humans. This finding suggests potential therapeutic benefits of oxpentifylline for treating clinical endotoxemia.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: